Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Siderowf

Showing results (1-10 of 182) with videos related to

Pageof 19
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2013
Bridging the credibility gap in cost effectiveness analysisAndrew Siderowf
Neurology|April 22, 2014
β-Amyloid in CSF: a window into Parkinson disease dementiaAndrew Siderowf, Giancarlo Logroscino
Parkinsonism & Related Disorders|February 27, 2018
Biomarkers for atypical Parkinsonism: Some progress, but much work remainsAndrew Feigin, Andrew Siderowf
Annals of Internal Medicine|April 16, 2003
Update on Parkinson diseaseAndrew Siderowf, Matthew Stern
Movement Disorders : Official Journal of the Movement Disorder Society|October 27, 2010
Cardiac denervation in rapid eye movement sleep behavior disorder and Parkinson's disease: getting to the heart of the matterAndrew Siderowf, Danna Jennings
Neurology|May 24, 2006
Clinical trials with rasagiline: evidence for short-term and long-term effectsAndrew Siderowf, Matthew Stern
Annals of Neurology|January 8, 2009
Premotor Parkinson's disease: clinical features, detection, and prospects for treatmentAndrew Siderowf, Matthew B Stern
Neurology|March 26, 2003
Progressive supranuclear palsy: Setting the scene for therapeutic trialsAndrew Siderowf, Niall P Quinn
Current Neurology and Neuroscience Reports|July 11, 2006
Preclinical diagnosis of Parkinson's disease: are we there yet?Andrew Siderowf, Matthew B Stern
Movement Disorders : Official Journal of the Movement Disorder Society|February 27, 2010
Parkinson's at risk syndrome: can Parkinson's disease be predicted?Matthew B Stern, Andrew Siderowf
Pageof 19

Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2013
Bridging the credibility gap in cost effectiveness analysisAndrew Siderowf
Neurology|April 22, 2014
β-Amyloid in CSF: a window into Parkinson disease dementiaAndrew Siderowf, Giancarlo Logroscino
Parkinsonism & Related Disorders|February 27, 2018
Biomarkers for atypical Parkinsonism: Some progress, but much work remainsAndrew Feigin, Andrew Siderowf
Annals of Internal Medicine|April 16, 2003
Update on Parkinson diseaseAndrew Siderowf, Matthew Stern
Movement Disorders : Official Journal of the Movement Disorder Society|October 27, 2010
Cardiac denervation in rapid eye movement sleep behavior disorder and Parkinson's disease: getting to the heart of the matterAndrew Siderowf, Danna Jennings
Neurology|May 24, 2006
Clinical trials with rasagiline: evidence for short-term and long-term effectsAndrew Siderowf, Matthew Stern
Annals of Neurology|January 8, 2009
Premotor Parkinson's disease: clinical features, detection, and prospects for treatmentAndrew Siderowf, Matthew B Stern
Neurology|March 26, 2003
Progressive supranuclear palsy: Setting the scene for therapeutic trialsAndrew Siderowf, Niall P Quinn
Current Neurology and Neuroscience Reports|July 11, 2006
Preclinical diagnosis of Parkinson's disease: are we there yet?Andrew Siderowf, Matthew B Stern
Movement Disorders : Official Journal of the Movement Disorder Society|February 27, 2010
Parkinson's at risk syndrome: can Parkinson's disease be predicted?Matthew B Stern, Andrew Siderowf
Pageof 19